LIFECORE BIOMEDICAL, INC. Amortization of Leased Asset
LIFECORE BIOMEDICAL, INC. (LFCR) reported Amortization of Leased Asset of $100.00 thousand for the 12-month period ending 2019-05-26, per its 10-K filed 2019-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfLeasedAsset · last filed 2019-08-01
- LIFECORE BIOMEDICAL, INC. amortization of leased asset for fiscal 2019 was $100.00K, a 0.00% change from fiscal 2018.
- LIFECORE BIOMEDICAL, INC. amortization of leased asset for fiscal 2018 was $100.00K, a 0.00% change from fiscal 2017.
- LIFECORE BIOMEDICAL, INC. amortization of leased asset for fiscal 2017 was $100.00K, a 104.08% increase from fiscal 2016.
- LIFECORE BIOMEDICAL, INC. amortization of leased asset for fiscal 2016 was $49.00K.
| Period end | Amortization of Leased Asset 12 month | Amortization of Leased Asset 12 month as first filed |
|---|---|---|
| 2019-05-26 | $100.00K 10-K · filed 2019-08-01 | |
| 2018-05-27 | $100.00K 10-K · filed 2019-08-01 | $135.00K 10-K · filed 2018-08-09 |
| 2017-05-28 | $100.00K 10-K · filed 2019-08-01 | $135.00K 10-K · filed 2017-08-11 |
| 2016-05-29 | $49.00K 10-K · filed 2018-08-09 | |
| 2015-05-31 | $0.00 10-K/A · filed 2018-03-15 | |
| 2014-05-25 | $0.00 10-K · filed 2016-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |